Studies of Myo-inositol and Plasmalogen Metabolism in Rat Brain

被引:0
作者
Beth Hoffman-Kuczynski
Nicholas V. Reo
机构
[1] WSU Magnetic Resonance Laboratory,Department of Biochemistry and Molecular Biology
[2] Cox Institute,Department of Physics
[3] Wright State University School of Medicine,undefined
[4] Wright State University School of Medicine,undefined
[5] WSU Magnetic Resonance Laboratory,undefined
[6] Cox Institute,undefined
来源
Neurochemical Research | 2004年 / 29卷
关键词
Phosphatidylethanolamine plasmalogen; myo-inositol; brain phospholipid metabolism;
D O I
暂无
中图分类号
学科分类号
摘要
Plasmalogens are ether-linked phospholipids that are abundant in nervous tissues. Their biological role is unclear, but may involve membrane structure/function and antioxidant activities. This study further investigates a recent report that chronic administration of myo-inositol in rats increased brain phosphatidylethanolamine plasmalogen (PlsEtn). We examined the effects of myo-inositol administration on the incorporation of [2-13C]ethanolamine ([2-13C]Etn) into rat brain phospholipids using NMR spectroscopy. Rats received either acute myo-inositol (single dose) ± [2-13C]Etn, or chronic myo-inositol (10-day treatment) + [2-13C]Etn. Controls received saline rather than myo-inositol. Acute myo-inositol produced a 68% increase in brain [myo-inositol] and an increase in the incorporation of [2-13C]Etn into phospholipids (P < .05). The PlsEtn/phosphatidylethanolamine ratio and the [PlsEtn] were increased by 27% and 30%, respectively. The PlsEtn content as a mole percentage of total phospholipids was elevated (P ≤ .05). Acute administration of myo-inositol + ethanolamine illustrates a positive correlation between the brain [myo-inositol] and the biosynthesis of ethanolamine phospholipids, with preferential synthesis of PlsEtn.
引用
收藏
页码:843 / 855
页数:12
相关论文
共 149 条
[1]  
Paltauf F.(1994)Ether lipids in biomembranes Chem. Phys. Lipids 74 101-139
[2]  
Brosche T.(1997)Plasmalogen phospholipids: Facts and theses to their antioxidative qualities Arch. Gerontol. Geriatr. 25 73-81
[3]  
Brosche T.(1998)The biological significance of plasmalogens in defense against oxidative damage Exp. Gerontol. 33 363-369
[4]  
Platt D.(1994)Plasmalogen phospholipids as potential protectors against lipid peroxidation of low density lipoproteins Biochem. Biophys. Res. Commun. 204 1235-1242
[5]  
Engelmann B.(1999)Inhibition of peroxyl radical-mediated lipid oxidation by plasmalogen phospholipids and α-tocopherol Free Radic. Biol. Med. 27 1087-1094
[6]  
Brautigam C.(1999)Contribution of copper binding to the inhibition of lipid oxidation by plasmalogen phospholipids Biochem. J. 340 377-383
[7]  
Thiery J.(1999)Susceptibility of plasmenyl glycerophosphoethanolamine lipids pertaining to oxidative degradation Free Radic. Biol. Med. 26 275-284
[8]  
Hahnel D.(1997)Delayed oxidative degradation of polyunsaturated diacyl phospholipids in the presence of plasmalogen phospholipids Biochem. J. 323 807-814
[9]  
Beyer K.(1999)The protective role of plasmalogens in iron-induced lipid peroxidation Free Radic. Biol. Med. 26 318-324
[10]  
Engelmann B.(1997)Effects of increasing times of incomplete cerebral ischemia upon the energy state and lipid peroxidation in the rat Exp. Brain Res. 134 230-241